TechBIZKON

TechBIZKON X LifeTECH+

9 Oct 2026 | Japan

PartnershipUpdated on 20 September 2026

Strategic Partnership for Diagnostics and Global Expansion

Board Director CFO at IMMUNOSENS Co., Ltd.

Osaka, Japan

About

IMMUNOSENS is an Osaka University spin-off developing a compact and quantitative point-of-care testing platform based on our proprietary GLEIA technology.

Our system enables rapid quantitative measurement using a very small sample volume and is designed for use not only in hospitals and clinics, but also in home healthcare and wellness applications.

We are seeking strategic partners in the following areas:

  • Business development and commercialization

  • Collaboration in diagnostics, healthcare, and chronic disease management

  • Joint product and technology development

  • Distribution and market access in Japan and overseas

  • Expansion into Europe and other global markets

  • Potential investment and strategic capital partnerships

We are particularly interested in discussions with pharmaceutical companies, medical device and diagnostic companies, healthcare providers, distributors, and investors who see potential in decentralized and home-based testing.

We would be pleased to explore opportunities for collaboration and long-term partnership.

Organisation

IMMUNOSENS Co., Ltd.

Startup

Osaka, Japan

Similar opportunities